CJC-1295 No DAC Research and Andropause Considerations

CJC-1295 without DAC is a research-grade analog of growth hormone releasing hormone (GHRH), supplied for laboratory research use only. It appears in discussions of andropause research because age-related decline in androgen signaling and age-related decline in growth hormone signaling are studied as parallel features of the aging endocrine system — so investigators looking at one frequently work with compounds that act on the other. For a wholesale buyer, the decision is not about the biology at all. It is about whether the supplier can prove identity and purity at the lot level, whether pricing is visible before you commit, and whether the documentation you hand to your own customers holds up. Nothing in this article describes human use, and nothing here is legal advice.

What the molecule actually is

CJC-1295 No DAC is a modified 29-amino-acid fragment of growth hormone releasing hormone, the same fragment class often catalogued as modified GRF (1-29). The "No DAC" designation matters: the DAC version carries a Drug Affinity Complex that binds serum albumin and substantially extends circulating half-life, while the No DAC form does not. That single structural difference is why the two are treated as distinct research tools rather than interchangeable variants, and why your customers will specify one or the other by name.

In laboratory research, the No DAC form is studied for its short-acting interaction with GHRH receptors on the anterior pituitary. Research suggests this shorter action profile more closely mirrors the body's own episodic GHRH signaling than long-acting analogs do, which is the property investigators studying somatotropic axis regulation tend to care about. That is a description of what the literature explores, not a claim about outcomes in people.

For procurement purposes, the practical consequences of the structure are stability and handling. Lyophilized peptides of this length are sensitive to moisture, heat excursion, and light, and reconstitution chemistry is the buyer's laboratory question — not something a supplier should be advising on. Any vendor offering usage guidance alongside a research compound is telling you something about how they read their own compliance obligations.

Why it comes up in age-related endocrine research

Andropause is the informal term for the gradual, age-associated decline in androgen production observed in men — distinct from the comparatively abrupt endocrine shift studied in menopause. It overlaps in the literature with what researchers sometimes call somatopause: the parallel age-related decline in growth hormone and IGF-1 signaling. Because those two axes decline on overlapping timelines and interact at multiple regulatory points, studies of one commonly reference the other.

That overlap is the whole reason a GHRH analog surfaces in andropause-adjacent research at all. Investigators are not studying CJC-1295 No DAC as an androgen; they are studying whether GHRH-receptor signaling behaves differently in aged versus young models, and how that intersects with androgen status. Research in this area is ongoing and far from settled, and the honest framing for any wholesale buyer is that the compound is a research tool for examining a pathway, not an answer to a condition.

This distinction is worth internalizing because it should shape how you describe the product. A catalog entry that connects CJC-1295 No DAC to "age-related decline" as a benefit is making a therapeutic claim. A catalog entry that says the compound is studied in research on somatotropic axis regulation is describing the science. The second version is accurate, is what serious buyers want to read, and is far less likely to create a problem for your business. Compounds sold by Real Peptides are for laboratory research use only, not for human or veterinary use — any question about administering a substance to a person or an animal belongs with a licensed physician or veterinarian, never with a peptide supplier.

Where it sits in a research catalog

Most buyers do not stock a single compound. They build a category. CJC-1295 No DAC 10mg sits in the growth-hormone-axis segment of a catalog alongside compounds like Ipamorelin 10mg and Tesamorelin 10mg, each of which is requested by name and each of which is studied through a different receptor mechanism.

Buyers serving customers interested in age-related research questions also tend to carry compounds from adjacent categories — mitochondrial and metabolic research tools such as MOTS-c 10mg, or cofactor products like the NAD+ Liquid Spray 1000mg. Breadth here is a commercial decision, not a scientific recommendation: nothing about stocking two compounds implies they are studied together, and your catalog copy should not suggest otherwise.

If you are mapping out a first order, the Longevity Peptides and Growth Factor & Tissue Signaling Research collections show how the category is organized and which SKUs move as a group.

How wholesale pricing and minimums actually work

Research peptide wholesale generally runs on volume tiers rather than a single flat rate. Unit cost steps down as committed volume rises, and most programs set a minimum order quantity either per SKU or across the total order. Beyond that structure, be skeptical of anyone quoting you industry-standard margins or payback timelines — those figures vary enormously by category, order size, and how you position your business, and any supplier stating them as a rule is guessing.

What separates a workable program from a frustrating one is usually not the headline price. It is whether the price is visible before you disclose your volume, whether documentation is included or billed separately, whether the tier you qualify for is stated plainly or negotiated case by case, and whether restock lead times are predictable enough to plan inventory against. A program that requires a sales call to learn the first number is a program that prices each buyer differently.

Ask specifically about what happens between orders, too. Lot-to-lot consistency, advance notice on formulation or vial changes, and whether a fresh certificate of analysis accompanies every new lot all matter more over a year of purchasing than a marginal difference in first-order unit cost.

What to verify before choosing any supplier

Purity claims are the least reliable part of this market, because a number printed on a website is not a test result. The verification work is straightforward, and it separates suppliers quickly.

The pattern worth watching for is documentation treated as a sales concession rather than a standard. When COAs are available only on request, only after payment, or only for an additional fee, the practical effect is that most buyers never check — which is usually the point.

The questions to put to your attorney

Research-use-only compounds sit in a regulatory space that is genuinely unsettled in places, and it is not an area where a supplier should be handing you conclusions. Rather than telling you what is permitted, here is what to resolve with your own counsel and your state board before you stock anything.

How does your state's professional licensing framework treat resale or distribution of research-use-only materials by a business of your type? Does your entity structure or professional license affect that answer? What labeling and record-keeping obligations attach to materials you resell, and how must research-use-only status be represented in your marketing? How do advertising and claim-substantiation rules apply to how you describe these compounds publicly? And what does your professional liability coverage actually cover with respect to this product category?

These answers vary by state and by business type, and they change. Get them in writing from an attorney licensed where you operate, and confirm the professional-licensing side with your state board directly. This section is informational only and is not legal advice.

What Real Peptides does differently

Real Peptides supplies research compounds at 99%+ HPLC purity, with seven-panel batch testing performed on every lot. Certificates of analysis are published and publicly verifiable — a prospective buyer can pull the lab results and read them before placing a first order, rather than requesting them afterward or paying for them separately. Orders ship from US fulfillment in 5–7 days, which makes restock cycles something you can plan inventory around instead of estimating.

Wholesale pricing tiers are part of the Wholesale Partner Program rather than a figure negotiated privately with each buyer. The application itself is three steps: submit the application, complete verification, and receive tier pricing and account access. There is no requirement to disclose projected volume before seeing what the program looks like.

The broader catalog spans the categories buyers in this space tend to build around, including Performance & Recovery Research and Mitochondrial & Metabolic Pathway Research compounds. Every item in it is supplied for laboratory research use only, is not an FDA-approved drug, and is not intended for human consumption.

Where to go from here

If you are evaluating suppliers for GHRH-analog research compounds and you want documentation you can show your own customers, the next step is to read the published COAs for the specific lots on offer, then apply to the Wholesale Partner Program at Real Peptides to see tier pricing for the volumes you actually plan to order.

Related reading on the Real Peptides site includes the product pages for CJC-1295 No DAC 10mg, Ipamorelin 10mg, and Tesamorelin 10mg, along with the Popular Peptides and Longevity Peptides collections.